Goldman Sachs Is Taking its Medicine. That’s Good News for Shareholders.
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
After seeing its consumer banking efforts struggle immensely in recent years, the investment banking powerhouse Goldman Sachs (NYSE: GS) announced at its investor day in February that it would pull back from its consumer banking ambitions, which it launched in 2016.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1282134935-d79a889de9c14d2e8dc74607247ad371-f34c21fb36324d68a65fe669914ca40b.jpg "Not All Retirement Accounts Should Be Tax-Sheltered")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2051030144-94590dcc863242d9b4bb756111ed63b3.jpg "The Difference Between Revocable and Irrevocable Inter Vivos Trusts")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1318886492-97d16b33b30c446a9b36843443f5c106.jpg "The Hidden Differences Among Index Funds")
:max_bytes(150000):strip_icc():format(jpeg)/Retired-couple-5680c8a33df78ccc15a96d7c-feca45f116ee46d4b2f042749188ee74.jpg "Using the Social Security Website to Get Answers")
:max_bytes(150000):strip_icc():format(jpeg)/Can-i-pay-student-loans-my-529-plan_final-0b67d5dceede437fb1bf7ecfdd34c0a5.png "Can a 529 Plan Be Applied to a Student Loan?")